Bionano Genomics (BNGO) X Mentions Statistics 2025

14 100%

1W 61.1%

Est. daily mentions of Cashtag on X.

Similar companies

Company		X Mentions
	Amgen AMGN	12 29.4%
	Gilead Sciences GILD	27 22.7%
	Catalyst Pharmaceuticals CPRX	1 50%
	Inovio Pharmaceuticals INO	15 150%
	Anavex Life Sciences AVXL	23 475%

Analyzing X Mentions, how is Bionano Genomics performing compared to its industry peers?

Bionano Genomics underperforms its industry peers when it comes to X Mentions, ranking in the 1st percentile.

Why should an investor track X mentions?

Investors should track mentions of Bionano Genomics on X because sudden increases in activity often reflect shifts in retail interest, sentiment, or breaking news. These signals can precede sharp price movements, offering valuable context for timing trades or identifying emerging opportunities.

Sentiment on X

The sentiment score for Bionano Genomics on X is 67 (out of 100). This is considered neutral.

Top Mentions

$BNGO Bionano Highlights Global Momentum Behind OGM at the 2025 Annual Meeting of the American Society...

Oct 23 - 1 retweets

$BNGO تسلط شركة Bionano الضوء على الزخم العالمي وراء OGM في الاجتماع...

Oct 23 - 1 retweets

$BNGO 08:07 on Oct. 23 2025 Bionano Genomics Highlighted Expanding Role Of Optical Genome Mapping In...

Oct 23 - 1 retweets

@Manic100x $BNGO - undervalued biotech gem 💎

Oct 21 - 0 retweets

About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.